Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Completed 73Unknown 23Terminated 12Recruiting 8Active not recruiting 4Withdrawn 3Not yet recruiting 2Suspended 1No longer available 1Enrolling by invitation 1Approved for marketing 1

Sponsor Class

OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Breast Neoplasms 542Neoplasms 381Carcinoma, Non-Small-Cell Lung 323Colorectal Neoplasms 296Lung Neoplasms 237Prostatic Neoplasms 220Carcinoma, Hepatocellular 212Stomach Neoplasms 155Pancreatic Neoplasms 155Leukemia, Myeloid, Acute 141Uterine Cervical Neoplasms 132Multiple Myeloma 130Recurrence 119Rectal Neoplasms 114Ovarian Neoplasms 109Neoplasm Metastasis 105Squamous Cell Carcinoma of Head and Neck 98Head and Neck Neoplasms 90Triple Negative Breast Neoplasms 86Esophageal Neoplasms 84Glioblastoma 81Endometrial Neoplasms 81Small Cell Lung Carcinoma 79Colonic Neoplasms 78Brain Neoplasms 77Melanoma 70Precursor Cell Lymphoblastic Leukemia-Lymphoma 65Hematologic Neoplasms 65Glioma 61Disease 60

Interventions

Tretinoin 1Lisaftoclax 1Arsenic Trioxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Leukemia, Promyelocytic, Acute × Clear all
NCT07597941 2026-06-04

Lisaftoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients

The Affiliated People's Hospital of Ningbo University

Phase 2/3 Not yet recruiting
60 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT07296445 2025-12-29

LATITUDE

SDK Therapeutics, Inc.

Phase 3 Not yet recruiting
120 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡